Form 4: Pfizer Executive Payal Sahni Reports Stock Transactions

Executive Vice President Payal Sahni reports the earn-out of stock appreciation rights and related transactions, including share withholding for tax obligations and exercise price payments.

Summary

• Payal Sahni, an Executive Vice President at Pfizer, reported transactions related to stock appreciation rights on February 23, 2024.
• Sahni earned out 11,527 stock appreciation rights at a price of $27.34.
• 905 shares were withheld to satisfy tax obligations at a price of $27.76.
• 9,314 shares were withheld to cover the exercise price of the stock appreciation rights at a price of $27.37.
• Following these transactions, Sahni directly owns 24,385 shares of common stock and indirectly owns 11,405 shares through a Rule 16b-3 plan.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't convey any positive or negative sentiment about the company's performance or future prospects.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, as required by the SEC. It provides transparency into the executive's holdings and transactions in the company's stock.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership of Pfizer stock.
• The transactions reflect part of the executive's compensation package.

Key Dates